Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo (Q36453976)

14 August 2017

Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo (English)

1 reference

eradication of infectious diseases

14 August 2017

1 reference

1 reference

7

N P Restifo

1 reference

14 August 2017

V Bronte

1

1 reference

14 August 2017

E Apolloni

2

1 reference

14 August 2017

R Ronca

3

1 reference

14 August 2017

P Zamboni

4

1 reference

14 August 2017

W W Overwijk

5

1 reference

14 August 2017

D R Surman

6

1 reference

14 August 2017

P Zanovello

8

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

14 August 2017

1 reference

14 August 2017

60

1 reference

14 August 2017

2

1 reference

14 August 2017

253-258

1 reference

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Inducing autoimmune disease to treat cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

A new era for cancer immunotherapy based on the genes that encode cancer antigens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4( ) T lymphocytes.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Tumor immunity and autoimmunity induced by immunization with homologous DNA

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Fc receptors are required in passive and active immunity to melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Human tumor antigens are ready to fly.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8 tumor-infiltrating lymphocytes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Enhanced immunogenicity for CD8 T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

T cell defined tumor antigens

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

The tyrosinase gene family--interactions of melanogenic proteins to regulate melanogenesis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

An improved plasmid DNA expression vector for direct injection into skeletal muscle

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Evidence for a differential avidity model of T cell selection in the thymus

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

CTL Response and Protection Against P815 Tumor Challenge in Mice Immunized with DNA Expressing the Tumor-Specific Antigen P815A

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2238820

Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10667570

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Anti-tyrosinase antibodies in malignant melanoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10667570

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

UKCCCR guidelines for the welfare of animals in experimental neoplasia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10667570

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

14 August 2017

PubMed publication ID

10667570

1 reference